Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (201-210 of 303) with videos related to

Pageof 31
Sort By:
Cancer Research and Treatment|September 12, 2018
Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung CancerKyung Hwa Lee, Yong Chan Ahn, Hongryull Pyo, et al.
Radiology|August 30, 2012
Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complicationsHyun Jung Yoon, Ho Yun Lee, Kyung Soo Lee, et al.
Radiation Oncology Journal|January 8, 2024
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancerSang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinomaSehhoon Park, Je-Gun Joung, Yang Won Min, et al.
Investigational New Drugs|April 10, 2017
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumorsSu Jin Lee, Seon Young Lee, Weon Sup Lee, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2015
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation testMoon Ki Choi, Jung Yong Hong, Won Jin Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.
Journal of Neuro-Oncology|September 17, 2015
Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancerKyung Rae Cho, Min Ho Lee, Doo-Sik Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Correction: The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid TumorsKyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, et al.
Cancer Research and Treatment|August 4, 2011
Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancerSu Jin Lee, Silvia Park, Hee Kyung Ahn, et al.
Pageof 31

Showing results (201-210 of 303) with videos related to

Sort By:
Pageof 31
Cancer Research and Treatment|September 12, 2018
Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung CancerKyung Hwa Lee, Yong Chan Ahn, Hongryull Pyo, et al.
Radiology|August 30, 2012
Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complicationsHyun Jung Yoon, Ho Yun Lee, Kyung Soo Lee, et al.
Radiation Oncology Journal|January 8, 2024
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancerSang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinomaSehhoon Park, Je-Gun Joung, Yang Won Min, et al.
Investigational New Drugs|April 10, 2017
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumorsSu Jin Lee, Seon Young Lee, Weon Sup Lee, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2015
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation testMoon Ki Choi, Jung Yong Hong, Won Jin Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trialSung Won Lim, Sehhoon Park, Youjin Kim, et al.
Journal of Neuro-Oncology|September 17, 2015
Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancerKyung Rae Cho, Min Ho Lee, Doo-Sik Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Correction: The First-week Proliferative Response of Peripheral Blood PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts the Response to Anti-PD-1 Therapy in Solid TumorsKyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, et al.
Cancer Research and Treatment|August 4, 2011
Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancerSu Jin Lee, Silvia Park, Hee Kyung Ahn, et al.
Pageof 31